Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2022.3788
Abstract: Importance Anti-vascular endothelial growth factor (VEGF) therapy for retinopathy of prematurity (ROP) has potential ocular and systemic advantages compared with laser, but we believe the systemic risks of anti-VEGF therapy in preterm infants are poorly… read more here.
Keywords: vegf therapy; anti vegf; therapy; preterm infants ... See more keywords
Injectable Anti‐Inflammatory Supramolecular Nanofiber Hydrogel to Promote Anti‐VEGF Therapy in Age‐Related Macular Degeneration Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Materials"
DOI: 10.1002/adma.202204994
Abstract: Age‐related macular degeneration (AMD) is a major cause of visual impairment and severe vision loss worldwide, while the currently available treatments are often unsatisfactory. Previous studies have demonstrated both inflammation and oxidative‐stress‐induced damage to the… read more here.
Keywords: age related; hydrogel; anti vegf; vegf therapy ... See more keywords
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
Sign Up to like & getrecommendations! Published in 2019 at "Acta Diabetologica"
DOI: 10.1007/s00592-019-01416-4
Abstract: To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under continued anti-VEGF therapy versus dexamethasone… read more here.
Keywords: anti vegf; vegf; year; continued anti ... See more keywords
Evaluation of vitreoretinal interface changes in patients receiving intravitreal anti-VEGF therapy
Sign Up to like & getrecommendations! Published in 2017 at "International Ophthalmology"
DOI: 10.1007/s10792-017-0490-x
Abstract: PurposeTo study the effects of repeated intravitreal injection of anti-VEGF drug bevacizumab on the vitreoretinal interface (VRI).MethodsPatients undergoing intravitreal injection of bevacizumab were enrolled. Eyes with media haze, uveitis, high myopia, history of cataract surgery… read more here.
Keywords: anti vegf; vitreoretinal interface; evaluation; interface ... See more keywords
Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti-VEGF Therapy for Diabetic Macular Edema in the United States.
Sign Up to like & getrecommendations! Published in 2021 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2021.03.010
Abstract: PURPOSE This study characterizes the association of risk factors including race, ethnicity, and insurance status with presenting visual acuity (VA) and diabetic retinopathy (DR) severity in patients initiating treatment with anti-vascular endothelial growth factor (VEGF)… read more here.
Keywords: anti vegf; initiation; treatment; insurance ... See more keywords
Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Cancer"
DOI: 10.1038/s41416-019-0725-x
Abstract: Background The mechanism of resistance development to anti-VEGF therapy in ovarian cancer is unclear. We focused on the changes in tumour immunity post anti-VEGF therapy. Methods The frequencies of immune cell populations and hypoxic conditions… read more here.
Keywords: anti vegf; csf; resistance; therapy ... See more keywords
Anti-VEGF therapy — a role in obesity-related breast cancer
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Endocrinology"
DOI: 10.1038/s41574-018-0021-5
Abstract: Obesity increases the risk of breast cancer and decreases the survival of patients with breast cancer, particularly for postmenopausal, oestrogen receptor-positive breast cancer. New findings now add to the evidence for the detrimental effects of… read more here.
Keywords: anti vegf; breast cancer; cancer; obesity ... See more keywords
Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2021.1952979
Abstract: INTRODUCTION Anti-angiogenesis therapy with intravitreal anti-VEGF agents is now the standard-of-care treatment for myopic choroidal neovascularization (CNV). AREAS COVERED We provide a critical review of the safety of all the anti-VEGF agents currently used for… read more here.
Keywords: anti vegf; myopic choroidal; safety; therapy ... See more keywords
Lessons Learned from PACORES in Proliferative Diabetic Retinopathy Management, Data from Latin America and Spain: The Asbury Lecture 2020.
Sign Up to like & getrecommendations! Published in 2021 at "Retina"
DOI: 10.1097/iae.0000000000003226
Abstract: PURPOSE To review the current literature on the management of proliferative diabetic retinopathy (PDR) and the challenges in the real-world setting. METHODS A review of the literature was performed on the therapeutic options for PDR,… read more here.
Keywords: anti vegf; diabetic retinopathy; management; proliferative diabetic ... See more keywords
Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2018-311963
Abstract: Background/aims To evaluate the 5-year visual and anatomical outcomes after anti-vascular endothelial growth factor (VEGF) therapy alone or in combination with photodynamic therapy (PDT), followed by pro re nata (PRN) anti-VEGF therapy with or without… read more here.
Keywords: anti vegf; year; macular atrophy; therapy without ... See more keywords
Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Diabetes Research"
DOI: 10.1155/2022/5779210
Abstract: Purpose To predict visual acuity (VA) 1 month after anti-vascular endothelial growth factor (VEGF) therapy in patients with diabetic macular edema (DME) by using machine learning. Methods This retrospective study included 281 eyes with DME… read more here.
Keywords: machine; anti vegf; machine learning; visual acuity ... See more keywords